牛牛AI助理已提取核心讯息三生制药公布2025年上半年业绩，期内收入43.56亿元人民币，同比微降0.8%。母公司拥有人应占纯利13.58亿元，同比增长24.6%。毛利率为85.3%，EBITDA为18.33亿元，同比增长11.6%。期内特比澳销售额23.71亿元，占公司总收入54.4%，在中国血小板减少症治疗市场份额达63.0%。公司研发投入持续加大，研发支出5.48亿元，同比增长15%，占收入...
Source Link牛牛AI助理已提取核心讯息三生制药公布2025年上半年业绩，期内收入43.56亿元人民币，同比微降0.8%。母公司拥有人应占纯利13.58亿元，同比增长24.6%。毛利率为85.3%，EBITDA为18.33亿元，同比增长11.6%。期内特比澳销售额23.71亿元，占公司总收入54.4%，在中国血小板减少症治疗市场份额达63.0%。公司研发投入持续加大，研发支出5.48亿元，同比增长15%，占收入...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.